Monashee Investment Management LLC

18 employees

Monashee Investment Management is a hedge fund.

Investor insights

Sectors invested in

Biotechnology21

Health Care19

Therapeutics8

Medical6

Medical Device5

Life Science4

Health Diagnostics4

Genetics4

Pharmaceutical4

Biopharma2

Clinical Trials2

research and development2

clinical trials2

oncology2

infectious disease1

Genome Engineering1

Fibrosis1

Inflammatory Bowel Disease1

Immunology1

Oncology1

Funding rounds participated in

$113M sweet spot round size

Most of their 26 investments are in rounds between $72M and $156M

Investor type

Hedge Fund

Basic info

Industry

financial services

Sectors

Business Development

Financial Services

Venture Capital

Date founded

2012

Investments made

Gossamer Bio raised $120M on July 13, 2022

Investors: The Invus Group, Weiss Asset Management and Monashee Investment Management LLC

MoonLake Immunotherapeutics AG raised $115M on April 6, 2022

Investors: RTW Investments, LP, Asymmetry Capital Management, L.P., Surveyor Capital, Tekla Capital Management and Monashee Investment Management LLC

Scipher Medicine raised $110M on February 24, 2022

Investors: Laurion Capital Management LP, ECHO, Hitachi Ventures, Optum Ventures, aMoon Fund, Khosla Ventures, Northpond Ventures and Monashee Investment Management LLC

AN2 Therapeutics raised $80M on January 7, 2022

Investors: Avidity Partners, RA Capital Management, L.P., Surveyor Capital and Monashee Investment Management LLC

Korro Bio, Inc. raised $116M on January 5, 2022

Investors: MP Healthcare Venture Management Inc, Qiming Venture Partners USA, The Invus Group, Surveyor Capital, Sixty Degree Capital, Point72 Asset Management, Wu Capital （双湖资本） and Monashee Investment Management LLC

Pardes Biosciences raised $75M on December 27, 2021

Investors: GMF CAPITAL, Foresite Capital, Frazier Healthcare Partners, Gilead Sciences, RA Capital Management, L.P., T. Rowe Price and Monashee Investment Management LLC

HotSpot Therapeutics, Inc. raised $100M on November 29, 2021

Investors: S.R. One Ltd, CaaS Capital Management, Sofinnova Partners, Revelation Partners, B Capital Group, Atlas Venture, LSP (Life Sciences Partners) and Monashee Investment Management LLC

Quell Therapeutics raised $156M on November 29, 2021

Investors: SV Life Sciences, Tekla Capital Management, Syncona Limited, JEITO, British Patient Capital, Ridgeback Capital Management LLC, Point72 Asset Management and Monashee Investment Management LLC

Better Therapeutics raised $70M on October 29, 2021

Investors: Sectoral Asset Management, Farallon Capital Management and Monashee Investment Management LLC

Undisclosed raised $200M on October 27, 2021

Investors: Infinite Capital, Rosecliff, K3 Ventures, Raptor Capital Management, Republic Capital, Venrock and Monashee Investment Management LLC